Jaundice in Polycystic Liver Disease: More Than Meets the Eye
Danielle Brandman – 12 April 2021
General Pitfalls in Imaging of Patients With Cirrhosis
Ali Morshid, Victoria Chernyak, Alice W. Fung, Khaled M. Elsayes – 12 April 2021
The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
Steven L. Flamm, Kimberly Brown, Hani M. Wadei, Robert S. Brown, Marcelo Kugelmas, Milagros Samaniego‐Picota, Patrizia Burra, Fred Poordad, Sammy Saab – 12 April 2021 – Acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]–AKI) is a severe and often fatal complication of end‐stage liver disease. The goals of treatment are to reverse renal failure and prolong survival in patients who are critically ill. However, interventions have limited efficacy, and mortality rates remain high.
Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease
Taisa Kohut, Jennifer Panganiban – 12 April 2021
Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis
Khaled Y. Elbanna, Ania Z. Kielar – 12 April 2021
Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis
Khaled Y. Elbanna, Ania Z. Kielar – 12 April 2021
Using LI‐RADS With Contrast‐Enhanced Ultrasound
Shuchi K. Rodgers, David T. Fetzer, Yuko Kono – 12 April 2021
Contrast‐Enhanced Ultrasound for Vascular Complications in the Transplant Liver
Shahrzad Sharafi, Bryan R. Foster, Alice Fung – 12 April 2021
LI‐RADS: Review and updates
Mohab Elmohr, Khaled M. Elsayes, Victoria Chernyak – 12 April 2021